RSV: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
Years
15184559606465-74≥ 75
Austria
RSV1
Belgium
RSV2
RSV3
Bulgaria
RSV4
Croatia
Cyprus
Czechia
Denmark
RSV5
Estonia
Finland
France
RSV6
RSV7
RSV
Germany
RSV8
RSV
Greece
RSV9
RSV10
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
RSV11
Malta
Netherlands
Norway
RSV12
Poland
RSV13
RSV14
Portugal
Romania
Slovakia
Slovenia
RSV15
Spain
RSV16
Sweden
RSV17
RSV17

Footnotes:

  1. More information: https://impfen.gv.at/impfungen/rsv or https://www.sozialministerium.gv.at/impfplan (p. 110ff)
  2. The vaccine is recommended and partially reimbursed for pregnant women between gestational weeks 28 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  3. Vaccine recommended to adults >60 years of age with comorbidities (partially reimbursed) and adults =75y (not reimbursed if no comorbidities): https://www.hgr-css.be/fr/avis/9837/vaccination-contre-le-vrs-adultes-revision-2022
  4. Immunization of pregnant women between 24 and 36 weeks of gestation. Vaccine and the administration are free of charge for pregnant women and funded by the National Health system.
  5. Vaccination during pregnancy. See https://www.ssi.dk/vaccinationer/vaccination-af-gravide
  6. The vaccine is offered to pregnant women between gestational weeks 32 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  7. Vaccine offered only to patients with risk factors.
  8. Vaccine offered only to persons with risk factors.
  9. 60-74 high risk groups
  10. All adults older than 75 years of age.
  11. The vaccine is offered to pregnant women between gestational weeks 32 and 36 as part of a dual strategy with monoclonal antibodies. vaccination can be proposed for Individuals 75+, especially residents in elderly care facilities, and 65+ with high-risk comorbidities (chronic respiratory or heart conditions, immunodeficiency, cancer, or blood malignancies)
  12. RSV-vaccine is recommended in pregnancy, but not part of the national vaccination program and costs are not covered.
  13. RSV vaccination recommended as free of charge for pregnant women in the 24-36 week of pregnancy
  14. RSV vaccination recommended to persons >60 years. Partial (50%) funding for persons 60-64 years old, free of charge for persons 65 years old and older.
  15. The vaccine is offered to pregnant women between gestational weeks 24 and 36. It is administered as a single-dose program all year round.
  16. Vaccination recommeded to specific risk groups. More information available at: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_GRadultos.pdf and https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/VRS/poblacionAdulta/docs/VRS_adulto_Actualizacion.pdf
  17. Vaccination is recommended for all people aged 75 and over. Vaccination is recommended for people aged 60 and over with certain diseases, diagnoses or conditions. More information https://www.folkhalsomyndigheten.se/vara-amnesomraden/vaccinationer/vaccinationer-a-o/vaccination-mot-rs-virus/